Dynavax (DVAX) Tops Q1 EPS by 3c

Dynavax (NASDAQ: DVAX) reported Q1 EPS of ($0.62), $0.03 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $5.6 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Change in Nonfarm Payrolls (Sep) 29K vs 90K Expected, Unemployment Rate 4.2%
• LTC Properties (LTC) PT Raised to $52 at RBC Capital